Literature DB >> 588805

Enkephalins and dorsal horn neurones of the cat: effects on responses to noxious and innocuous skin stimuli.

A W Duggan, J G Hall, P M Headley.   

Abstract

1. In spinal cats anaesthetized with alpha-chloralose, a study was made of the effects of methionine enkephalin and methionine enkephalin amide on the responses of neurones of spinal laminae IV and V to noxious and innocuous skin stimuli. The enkephalins were ejected from micropipettes either in the region of cell bodies or in the substantia gelatinosa. 2. Administered near cell bodies the enkephalins reduced spontaneous firing and cell responses to both types of skin stimuli. These effects were antagonized by naloxone when administered near cell bodies but not when given intravenously in doses (0.3-0.6 mg/kg) more than adequate to antagonize analgesic doses of morphine. 3. Administered in the substantia gelatinosa the enkephalins were more selective in their action. The predominant effect was a reduction in nociceptive responses with little effect on non-nociceptive responses although spontaneous firing was commonly reduced. Naloxone administered either in the substantia gelatinosa or intravenously (0.1-0.3 mg/kg) reversed these effects of the enkephalins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588805      PMCID: PMC1667882          DOI: 10.1111/j.1476-5381.1977.tb08432.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Morphine, enkephalin and the substantia gelatinosa.

Authors:  A W Duggan; J G Hall; P M Headley
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

2.  Interactions of peptides derived from the C-fragment of beta-lipotropin with brain opiate receptors [proceedings].

Authors:  N J Birdsall; A F Bradbury; A S Burgen; E C Hulme; D G Smyth; C R Snell
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

3.  Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats.

Authors:  W Zieglgänsberger; J P Fry; A Herz; L Moroder; E Wünsch
Journal:  Brain Res       Date:  1976-10-08       Impact factor: 3.252

4.  Effects induced by stimulation of the centralis inferior nucleus of the raphe on dorsal horn interneurons in cat's spinal cord.

Authors:  G Guilbaud; J L Oliveras; G Giesler; J M Besson
Journal:  Brain Res       Date:  1977-05-06       Impact factor: 3.252

5.  Hyperpolarization of myenteric neurones by enkephalin [proceedings].

Authors:  R A North
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Enkephalin-induced depression of single neurons in brain areas with opiate receptors--antagonism by naloxone.

Authors:  R C Frederickson; F H Norris
Journal:  Science       Date:  1976-10-22       Impact factor: 47.728

7.  The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat.

Authors:  W Zieglgänsberger; H Bayerl
Journal:  Brain Res       Date:  1976-10-08       Impact factor: 3.252

8.  Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla.

Authors:  S F Atweh; M J Kuhar
Journal:  Brain Res       Date:  1977-03-18       Impact factor: 3.252

9.  Suppression of transmission of nociceptive impulses by morphine: selective effects of morphine administered in the region of the substantia gelatinosa.

Authors:  A W Duggan; J G Hall; P M Headley
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

10.  Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.

Authors:  N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  14 in total

1.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

Authors:  A W Mudge; S E Leeman; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 2.  Neuroanatomy of the pain system and of the pathways that modulate pain.

Authors:  W D Willis; K N Westlund
Journal:  J Clin Neurophysiol       Date:  1997-01       Impact factor: 2.177

3.  Reduced numbers of calcitonin gene-related peptide-(CGRP-) and tachykinin-immunoreactive sensory neurones associated with greater enkephalin immunoreactivity in the dorsal horn of a mutant rat with hereditary sensory neuropathy.

Authors:  S Kar; S J Gibson; F Scaravilli; J M Jacobs; V R Aber; J M Polak
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

Review 4.  Neurotransmitters in subcortical somatosensory pathways.

Authors:  J Broman
Journal:  Anat Embryol (Berl)       Date:  1994-03

5.  Methyl xanthines, adenosine 3',5'-cyclic monophosphate and the spinal transmission of nociceptive information.

Authors:  A W Duggan; B T Griersmith
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

6.  The contributions of mu-, delta- and kappa-opioid receptors to the actions of endogenous opioids on spinal reflexes in the rabbit.

Authors:  R W Clarke; T W Ford
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

7.  Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones.

Authors:  A F Sullivan; A H Dickenson; B P Roques
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

8.  Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.

Authors:  K Jhamandas; M Sutak
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

9.  Naloxone enhancement of spinal reflexes in the rabbit.

Authors:  D M Catley; R W Clarke; J E Pascoe
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

10.  Selective antinociceptive effects of tizanidine (DS 103-282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord.

Authors:  J Davies; S E Johnston
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.